Chemistry Reference
In-Depth Information
17. Seo, A., Holm, P., Kristensen, H., and Schaefer, T. (2003) The preparation of agglomerates
containing solid dispersions of diazepam by melt agglomeration in a high shear mixer.
Int. J.
Pharm.
, 259(1-2):161-171.
18. Gupta, M.K., Tseng, Y.-C., Goldman, D., and Bogner, R.H. (2002) Hydrogen bonding with
adsorbent during storage governs drug dissolution from solid-dispersion granules.
Pharm.
Res.
, 19(11):1663-1672.
19. Hurter, P., Thomas, H., Nadig, D., Embiata-Smith, D., and Paone, A. (2013) Implementing
continuous manufacturing to streamline and accelerate drug development.
AAPS News-
magazine
, August, pp. 14-19.
20. Schaber, S.D., Gerogiorgis, D.I., Ramachandran, R., Evans, J.M., Barton, P.I., and Trout, B.L.
(2011) Economic analysis of integrated continuous and batch pharmaceutical manufacturing: a
case study.
Ind. Eng. Chem. Res.
, 50(17):10083-10092.
21. Paudel, A., Worku, Z., Meeus, J., Guns, S., and Van den Mooter, G. (2013) Manufacturing of
solid dispersions of poorly water soluble drugs by spray drying.
Int. J. Pharm.
,
453(1):253-284.
22. Srinarong, P., de Waard, H., Frijlink, H.W., and Hinrichs, W.L.J. (2011) Improved dissolution
behavior of lipophilic drugs by solid dispersions: the production process as starting point for
formulation considerations.
Expert Opin. Drug Deliv.
, 8(9):1121-1140.
23. Bikiaris, D.N. (2011) Solid dispersions, part I: recent evolutions and future opportunities in
manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Expert Opin. Drug Deliv.
, 8(11):1501-1519.
24. Shah, N., Iyer, R.M., Mair, H.-J., Choi, D., Tian, H., Diodone, R. et al. (2013) Improved
human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous
polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process.
J. Pharm. Sci.
, 102(3):967-981.
25. Sertsou, G., Butler, J., Scott, A., Hempenstall, J., and Rades, T. (2002) Factors affecting
incorporation of drug into solid solution with HPMCP during solvent change co-precipitation.
Int. J. Pharm.
, 245(1-2):99-108.
26. Shah, N., Sandhu, H., Phuapradit, W., Pinal, R., Iyer, R., Albano, A. et al. (2012) Development
of novel microprecipitated bulk powder (MBP) technology for manufacturing stable amor-
phous formulations of poorly soluble drugs.
60.
27. Won, D.-H., Kim, M.-S., Lee, S., Park, J.-S., and Hwang, S.-J. (2005) Improved physico-
chemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent
precipitation process.
Int. J. Pharm.
, 301(1-2):199-208.
28. De Zordi, N., Moneghini, M., Kikic, I., Grassi, M., Del Rio Castillo, A., Solinas, D. et al.
(2012) Applications of supercritical fluids to enhance the dissolution behaviors of furosemide
by generation of microparticles and solid dispersions.
Int. J. Pharm.
, 438(1
-
2):53
-
Eur. J. Pharm. Biopharm.
,
81(1):131-141.
29. Puri, V., Dantuluri, A.K., and Bansal, A.K. (2011) Investigation of atypical dissolution
behavior of an encapsulated amorphous solid dispersion.
J. Pharm. Sci.
, 100(6):2460-2468.
30. Puri, V., Dantuluri, A.K., and Bansal, A.K. (2012) Barrier coated drug layered particles for
enhanced performance of amorphous solid dispersion dosage form.
J. Pharm. Sci.
,
101(1):342-353.
31. Food and Drug Administration (2012)
Guidance for Industry PAT—A Framework for
Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
. Available
